Response rates and durability of chemotherapy among 62 patients with metastatic Merkel cell carcinoma

Cytotoxic chemotherapy is commonly used to treat advanced Merkel cell carcinoma (MCC). However, its efficacy in distant metastatic MCC patients is unclear, in part because most prior reports aggregated these patients with those receiving adjuvant chemotherapy and combined chemoradiation for whom pro...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancer Med
Glavni autori: Iyer, Jayasri G., Blom, Astrid, Doumani, Ryan, Lewis, Christopher, Tarabadkar, Erica S., Anderson, Austin, Ma, Christine, Bestick, Amy, Parvathaneni, Upendra, Bhatia, Shailender, Nghiem, Paul
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2016
Teme:
Clinical Cancer Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5055152/
https://ncbi.nlm.nih.gov/pubmed/27431483
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.815
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items